Geode Capital Management, LLC Gh Research PLC Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Gh Research PLC stock. As of the latest transaction made, Geode Capital Management, LLC holds 69,421 shares of GHRS stock, worth $631,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,421

Previous 69,611 0.27%

Holding current value

$631,036

Previous $811,000 42.79%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$6.69 - $12.49 $1,271 - $2,373	-190 Reduced 0.27%	69,421 $464,000
Q2 2024 Aug 09, 2024	BUY	$10.5 - $14.81 $8,778 - $12,381	836 Added 1.22%	69,611 $811,000
Q1 2024 May 13, 2024	BUY	$5.34 - $11.09 $35,655 - $74,047	6,677 Added 10.75%	68,775 $733,000
Q4 2023 Feb 13, 2024	BUY	$5.26 - $11.04 $25,847 - $54,250	4,914 Added 8.59%	62,098 $360,000
Q3 2023 Nov 13, 2023	BUY	$9.8 - $14.15 $70,119 - $101,243	7,155 Added 14.3%	57,184 $574,000
Q2 2023 Aug 11, 2023	BUY	$7.88 - $12.74 $1,646 - $2,662	209 Added 0.42%	50,029 $593,000
Q1 2023 May 15, 2023	BUY	$6.02 - $10.92 $10,474 - $19,000	1,740 Added 3.62%	49,820 $398,000
Q4 2022 Feb 13, 2023	BUY	$9.2 - $13.5 $18,096 - $26,554	1,967 Added 4.27%	48,080 $464,000
Q3 2022 Nov 14, 2022	BUY	$10.15 - $16.15 $8,221 - $13,081	810 Added 1.79%	46,113 $535,000
Q2 2022 Aug 12, 2022	BUY	$8.99 - $19.87 $2,876 - $6,358	320 Added 0.71%	45,303 $452,000
Q1 2022 May 13, 2022	BUY	$15.48 - $23.98 $5,418 - $8,393	350 Added 0.78%	44,983 $822,000
Q4 2021 Feb 11, 2022	BUY	$14.1 - $27.9 $245,833 - $486,436	17,435 Added 64.1%	44,633 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$16.51 - $23.68 $449,038 - $644,048	27,198 New	27,198 $599,000

Others Institutions Holding GHRS

# of Institutions

Shares Held

27.8M

Call Options Held

2.8K

Put Options Held

3.8K

View Full List

About GH Research PLC

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $473M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

More about GHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Gh Research PLC Transaction History